Contrasting Adynxx (OTCMKTS:ADYX) and Sintx Technologies (NASDAQ:SINT)

Sintx Technologies (NASDAQ:SINT) and Adynxx (OTCMKTS:ADYX) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Profitability

This table compares Sintx Technologies and Adynxx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-421.17%	-84.05%	-52.33%
Adynxx	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Sintx Technologies and Adynxx, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	0	0	1	0	3.00
Adynxx	0	0	0	0	N/A

Sintx Technologies presently has a consensus target price of $22.00, indicating a potential upside of 5,182.11%. Given Sintx Technologies’ higher possible upside, equities research analysts plainly believe Sintx Technologies is more favorable than Adynxx.

Risk & Volatility

Sintx Technologies has a beta of 1.8, indicating that its stock price is 80% more volatile than the S&P 500. Comparatively, Adynxx has a beta of 2.68, indicating that its stock price is 168% more volatile than the S&P 500.

Institutional & Insider Ownership

2.7% of Sintx Technologies shares are owned by institutional investors. 1.0% of Sintx Technologies shares are owned by insiders. Comparatively, 17.4% of Adynxx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Sintx Technologies and Adynxx’s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$895,000.00	1.97	-$12.04 million	N/A	N/A
Adynxx	N/A	N/A	N/A	N/A	N/A

Adynxx has lower revenue, but higher earnings than Sintx Technologies.

Summary

Adynxx beats Sintx Technologies on 5 of the 9 factors compared between the two stocks.

About Sintx Technologies

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

About Adynxx

Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.